Bernard r. Chaitman

Bernard r. Chaitman's AcademicInfluence.com Rankings

Bernard r. Chaitman

Medical

#1223

World Rank

#1542

Historical Rank

Cardiology

#82

World Rank

#83

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Bernard r. Chaitman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bernard r. Chaitman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. (2000) (4196)
Third universal definition of myocardial infarction. (2012) (4123)
Optimal medical therapy with or without PCI for stable coronary disease. (2007) (3509)
Third universal definition of myocardial infarction (2012) (3338)
Fourth Universal Definition of Myocardial Infarction (2018). (2018) (2724)
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. (2011) (2581)
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (2006) (2558)
ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). (2002) (2258)
Effects of dalcetrapib in patients with a recent acute coronary syndrome. (2012) (1782)
A randomized trial of therapies for type 2 diabetes and coronary artery disease. (2009) (1778)
Fourth universal definition of myocardial infarction (2018). (2018) (1537)
ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluat (2002) (1523)
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study. (2001) (1507)
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy (2008) (1505)
ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). (2002) (1400)
Statement on exercise. Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart association. (1992) (1282)
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. (2001) (1237)
Liberal or restrictive transfusion in high-risk patients after hip surgery. (2011) (1169)
Initial Invasive or Conservative Strategy for Stable Coronary Disease. (2020) (1071)
Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. (2003) (979)
Third universal definition of myocardial infarction. (2012) (921)
Survival of Medically Treated Patients in the Coronary Artery Surgery Study (CASS) Registry (1982) (781)
Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). (1996) (780)
Third universal definition of myocardial infarction. (2012) (751)
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. (2004) (648)
Idiopathic Short QT Interval:A New Clinical Syndrome? (2001) (602)
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Improvement of cardiac ischemia at 1 year after PTCA and CABG. (1995) (580)
Myonecrosis after revascularization procedures. (1998) (572)
Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. (2004) (567)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). (2015) (560)
Long‐term Survival of Medically Treated Patients in the Coronary Artery Surgery Study (CASS) Registry (1994) (547)
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. (2004) (535)
Statement on exercise: benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. (1996) (531)
Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. (1995) (526)
Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators. (1995) (508)
The Brugada syndrome: clinical, electrophysiologic and genetic aspects. (1999) (505)
Angiographic Prevalence of High‐risk Coronary Artery Disease in Patient Subsets (CASS) (1981) (489)
[Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Executive summary]. (2006) (485)
ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery—Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluati (2002) (479)
Clinical, Angiographic, and Hemodynamic Findings in Patients with Anomalous Origin of the Coronary Arteries (1976) (453)
Fourth Universal Definition of Myocardial Infarction (2018). (2018) (429)
Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS). (1981) (428)
A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators. (1990) (423)
Third universal definition of myocardial infarction. (2012) (408)
Inhibition of the Sodium-Hydrogen Exchanger With Cariporide to Prevent Myocardial Infarction in High-Risk Ischemic Situations: Main Results of the GUARDIAN Trial (2000) (393)
Recommendations for cardiovascular screening, staffing, and emergency policies at health/fitness facilities. (1998) (389)
36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes With Cardiovascular Abnormalities (2005) (388)
Exercise Stress Testing (1979) (385)
Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. (1984) (378)
[ACC/AHA/ESC 2006 guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary]. (2006) (378)
Gender Differences in the Noninvasive Evaluation and Management of Patients with Suspected Coronary Artery Disease (1994) (377)
Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investigators and Staff. (1993) (366)
Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study. (2001) (338)
Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). (1983) (330)
Assessment of functional capacity in clinical and research applications: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. (2000) (321)
Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. (1989) (320)
Secondary Prevention of Coronary Heart Disease in the Elderly (With Emphasis on Patients ≥75 Years of Age): An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention (2002) (320)
Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. (1996) (315)
Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. (2013) (303)
Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI) (1998) (301)
Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. (2006) (285)
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. (2018) (285)
Exercise stress testing. Correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Surgery Study (CASS). (1980) (284)
Correlation of pharmacological 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses. (1994) (284)
Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. (1998) (258)
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials (2018) (248)
Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry. (1989) (246)
The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease: Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction (2009) (245)
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidel (2006) (244)
Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. (2008) (239)
Management of Coronary Disease in Patients with Advanced Kidney Disease. (2020) (239)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). (2015) (235)
Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. Coronary Artery Surgery Study. (1995) (232)
Exercise Standards for Testing and Training (2001) (228)
Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes. (2015) (215)
Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. (2015) (206)
Multilesion coronary angioplasty: clinical and angiographic follow-up. (1987) (205)
ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluat (2002) (204)
Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). (1994) (203)
Significance of silent myocardial ischemia during exercise testing in patients with coronary artery disease. (1987) (202)
Improved Efficiency of Treadmill Exercise Testing Using a Multiple Lead ECG System and Basic Hemodynamic Exercise Response (1978) (198)
Effects of Atorvastatin on Stroke in Patients With Unstable Angina or Non-Q-Wave Myocardial Infarction: A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Substudy (2002) (193)
Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina). (2013) (191)
Noninvasive diagnostic test choices for the evaluation of coronary artery disease in women: a multivariate comparison of cardiac fluoroscopy, exercise electrocardiography and exercise thallium myocardial perfusion scintigraphy. (1984) (190)
Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. (2011) (189)
Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience. (1995) (188)
Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. (2005) (187)
Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. (2009) (187)
Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. (2012) (184)
Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia. (2014) (182)
Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial (2015) (182)
Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes. (2006) (179)
Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology. (2014) (179)
Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators. (1995) (179)
Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial. (2009) (174)
Skeletal muscle adaptation in adolescent boys: sprint and endurance training and detraining. (1982) (174)
Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements. (1995) (172)
The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators. (2000) (171)
An Electrocardiogram Should Not Be Included in Routine Preparticipation Screening of Young Athletes (2007) (169)
Fourth universal definition of myocardial infarction (2018). (2019) (169)
ACC/AHA Guideline Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery (2002) (152)
Exercise Technetium‐99m Sestamibi Tomography for Cardiac Risk Stratification of Patients With Stable Chest Pain (1994) (151)
Immediate and short-term benefit of multilesion coronary angioplasty: influence of degree of revascularization. (1985) (150)
Use of Survival Analysis to Determine the Clinical Significance of New Q Waves After Coronary Bypass Surgery (1983) (150)
Evaluation of the Glycometabolic Effects of Ranolazine in Patients With and Without Diabetes Mellitus in the MERLIN-TIMI 36 Randomized Controlled Trial (2009) (148)
The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. (2006) (145)
Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial. (2001) (144)
Fourth Universal Definition of Myocardial Infarction (2018). (2018) (144)
Exercise Electrocardiography and Myocardial Scintigraphy in the Serial Evaluation of the Results of Percutaneous Transluminal Coronary Angioplasty (1982) (142)
Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation. (1998) (140)
ECG phenomenon called the J wave. History, pathophysiology, and clinical significance. (1995) (138)
Angiographic evaluation of the natural history of normal coronary arteries and mild coronary atherosclerosis. (1978) (136)
The role of exercise testing in identifying patients with improved survival after coronary artery bypass surgery. (1986) (135)
Coronary Artery Spasm During Exercise in Patients with Variant Angina (1979) (127)
Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators. (2000) (126)
Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. (1996) (125)
Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial. (1997) (124)
Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. (1994) (123)
Perioperative and long-term prognostic value of intravenous dipyridamole thallium scintigraphy in patients with peripheral vascular disease. (1990) (121)
Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB). (1997) (121)
Safety and diagnostic accuracy of dipyridamole-thallium imaging in the elderly. (1988) (119)
The changing role of the exercise electrocardiogram as a diagnostic and prognostic test for chronic ischemic heart disease. (1986) (115)
The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial. (1994) (114)
Diagnostic accuracy of exercise ECG lead systems in clinical subsets of women. (1982) (113)
Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty. (1988) (113)
The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty. (1987) (111)
Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. (2010) (111)
Clinical and Angiographic Correlates of Exercise‐induced ST‐segment Elevation: Increased Detection with Multiple ECG Leads (1980) (110)
Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study. (2003) (109)
Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS) (2006) (109)
Safety and utility of exercise testing in emergency room chest pain centers: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. (2000) (108)
Prognostic importance of silent myocardial ischemia detected by intravenous dipyridamole thallium myocardial imaging in asymptomatic patients with coronary artery disease. (1989) (107)
Long-term prognostic value of exercise testing in men and women from the Coronary Artery Surgery Study (CASS) registry. (1995) (105)
Prognostic value of intravenous dipyridamole thallium scintigraphy after an acute myocardial ischemic event. (1989) (99)
Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge. (2007) (95)
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial (2019) (95)
Effects of carbon monoxide on myocardial ischemia. (1991) (94)
The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression. (1998) (94)
Diagnostic Quantification of CASS (Coronary Artery Surgery Study) Clinical and Exercise Test Results in Determining Presence and Extent of Coronary Artery Disease: A Multivariate Approach (1981) (92)
Detrimental effect of perioperative myocardial infarction on late survival after coronary artery bypass. Report from the Coronary Artery Surgery Study--CASS. (1984) (92)
Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: an abridged version of the report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (1997) (91)
Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424. (2006) (91)
Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). (2013) (90)
Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction. (1998) (88)
Significance of silent myocardial ischemia during exercise testing in patients with diabetes mellitus: a report from the Coronary Artery Surgery Study (CASS) Registry. (1991) (88)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials (2015) (87)
Coronary Artery Surgery Study (CASS): comparability of 10 year survival in randomized and randomizable patients. (1990) (86)
Coronary angioplasty: a therapeutic option for symptomatic patients with two and three vessel coronary disease. (1988) (85)
Rapid ventricular repolarization in rodents: electrocardiographic manifestations, molecular mechanisms, and clinical insights. (2000) (85)
Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration. (1984) (85)
Diagnostic criteria and prognosis of perioperative myocardial infarction following coronary bypass. (1983) (85)
Value of exercise testing in determining the risk classification and the response to coronary artery bypass grafting in three-vessel coronary artery disease: a report from the Coronary Artery Surgery Study (CASS) registry. (1987) (84)
Operative risk factors in patients with left main coronary-artery disease. (1980) (84)
NOVACODE serial ECG classification system for clinical trials and epidemiologic studies. (1992) (84)
The Importance of Clinical Subsets in Interpreting Maximal Treadmill Exercise Test Results: the Role of Multiple-Lead ECG Systems (1979) (83)
Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study. (1995) (80)
The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial. (2007) (80)
Beneficial Effect of Intravenous Diltiazem in the Acute Management of Paroxysmal Supraventricular Tachyarrhythmias (1983) (80)
Total occlusion of the left main coronary artery: the Coronary Artery Surgery Study (CASS) experience. (1982) (80)
Risk of developing an acute myocardial infarction or sudden coronary death in patients with exercise-induced silent myocardial ischemia. A report from the Coronary Artery Surgery Study (CASS) registry. (1988) (79)
[Fourth universal definition of myocardial infarction (2018)]. (2018) (78)
Heparin-induced prolongation of partial thromboplastin time after thrombolysis: relation to coronary artery patency. HART Investigators. (1992) (78)
Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II Trial. (1993) (77)
Prediction of Multivessel Disease after Inferior Myocardial Infarction (1978) (77)
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity (2021) (77)
Prognostic value of intravenous dipyridamole thallium imaging in patients with diabetes mellitus considered for renal transplantation. (1990) (76)
The QT interval and risk of incident atrial fibrillation. (2013) (74)
Significance of exercise-induced ventricular arrhythmia in stable coronary artery disease: a coronary artery surgery study project. (1984) (74)
Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial). (2009) (73)
Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial. (2020) (73)
Effect of coronary artery disease on Doppler-derived parameters of aortic flow during upright exercise. (1986) (72)
Diabetics with coronary disease have a prevalence of asymptomatic ischemia during exercise treadmill testing and ambulatory ischemia monitoring similar to that of nondiabetic patients. An ACIP database study. ACIP Investigators. Asymptomatic Cardiac Ischemia Pilot Investigators. (1996) (71)
Relationship among mental stress-induced ischemia and ischemia during daily life and during exercise: the Psychophysiologic Investigations of Myocardial Ischemia (PIMI) study. (1999) (70)
Prognostic value of dipyridamole thallium-201 imaging in elderly patients. (1992) (70)
Increased Exercise Tolerance and Reduced Electrocardiographic Ischemia with Diltiazem in Patients with Stable Angina Pectoris (1982) (68)
Detection of Multivessel Coronary Disease After Myocardial Infarction Using Exercise Stress Testing and Multiple ECG Lead Systems (1980) (68)
Association of Myocardial Enzyme Elevation and Survival Following Coronary Artery Bypass Graft Surgery (2012) (65)
Comparison of the various electrocardiographic scoring codes for estimating anatomically documented sizes of single and multiple infarcts of the left ventricle. (1998) (65)
Comparative sensitivity and specificity of exercise electrocardiographic lead systems. (1981) (64)
Double‐Blind, Dose‐Response, Placebo‐Controlled Multicenter Study of Nisoldipine: A New Second‐Generation Calcium Channel Blocker in Angina Pectoris (1991) (64)
Improved interpretation of exercise Tl-201 myocardial perfusion scintigraphy in women: characterization of breast attenuation artifacts. (1987) (64)
Independent value of signal-averaged electrocardiography and left ventricular function in identifying patients with sustained ventricular tachycardia with coronary artery disease. (1987) (64)
Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial. (2009) (64)
Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI). (1999) (64)
Task Force 6: coronary artery disease. (2005) (64)
Doppler and two-dimensional echocardiographic assessment of left ventricular function before and after intravenous dipyridamole stress testing for detection of coronary artery disease. (1988) (62)
Comparison of accuracy for detecting coronary artery disease and side-effect profile of dipyridamole thallium-201 myocardial perfusion imaging in women versus men. (1992) (61)
A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects. (1985) (59)
Determination of perioperative cardiac risk by adenosine thallium-201 myocardial imaging. (1992) (59)
Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease (2012) (59)
Impact of Age on Clinical Outcome and Postlytic Management Strategies in Patients Treated With Intravenous Thrombolytic Therapy: Results From the TIMI II Study (1994) (59)
Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists. (2004) (59)
The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. The TIMI Investigators. (1989) (58)
Preoperative clinical assessment and dipyridamole thallium-201 scintigraphy for prediction and prevention of cardiac events in patients having major noncardiovascular surgery and known or suspected coronary artery disease. (1994) (58)
Importance of coronary collateral circulation in interpreting exercise test results. (1981) (58)
Comparison of coronary artery bypass surgery and medical therapy in patients with exercised-induced silent myocardial ischemia: a report from the Coronary Artery Surgery Study (CASS) registry. (1988) (57)
Prevalence and prognostic significance of silent and symptomatic ischemia after coronary bypass surgery: a report from the Coronary Artery Surgery Study (CASS) randomized population. (1991) (56)
A logistic regression analysis of multiple noninvasive tests for the prediction of the presence and extent of coronary artery disease in men. (1985) (56)
Preservation of the Myocardium During Coronary Artery Bypass Grafting (1981) (56)
Comparison of the Asymptomatic Cardiac Ischemia Pilot and modified Asymptomatic Cardiac Ischemia Pilot versus Bruce and Cornell exercise protocols. (1993) (56)
The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease. (2010) (55)
A life table and Cox regression analysis of patients with combined proximal left anterior descending and proximal left circumflex coronary artery disease: non-left main equivalent lesions (CASS). (1983) (55)
Significance of exercise-induced junctional S-T depression in evaluation of coronary artery disease. (1977) (54)
Abnormal heart rate responses to exercise predict increased long-term mortality regardless of coronary disease extent: the question is why? (2003) (54)
Transdermal nitroglycerin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction: results of a multicenter prospective randomized, double-blind, placebo-controlled trial. (1998) (53)
A Randomized, Placebo‐Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina (2012) (53)
Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease. (2016) (52)
Comparative prognostic value of clinical risk indexes, resting two-dimensional echocardiography, and dipyridamole stress thallium-201 myocardial imaging for perioperative cardiac events in major nonvascular surgery patients. (1993) (52)
Long-term cardiopulmonary exercise performance after heart transplantation. (1996) (52)
Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy: Observations From the COURAGE Trial (2011) (52)
Clinical and Angiographic Risk Stratification and Differential Impact on Treatment Outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial (2012) (51)
Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues. (2008) (51)
Bypass Angioplasty Revascularization Investigation (BARI): baseline clinical and angiographic data. (1995) (51)
Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials. (1995) (51)
The novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression (1998) (51)
Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study) (1997) (50)
Hemodynamic Evaluation of the Carpentier‐Edwards Porcine Xenograft (1979) (50)
Baseline Characteristics of Patients with Diabetes and Coronary Artery Disease Enrolled in the BARI 2D Trial (2008) (50)
Automated external defibrillators in health/fitness facilities: supplement to the AHA/ACSM Recommendations for Cardiovascular Screening, Staffing, and Emergency Policies at Health/Fitness Facilities. (2002) (49)
Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study. (1999) (49)
Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons. (2020) (49)
S-T segment elevation and coronary spasm in response to exercise. (1981) (49)
Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study. (1992) (49)
ST segment elevation with exercise: a marker for poor ventricular function and poor prognosis. Coronary Artery Surgery Study (CASS) confirmation of Seattle Heart Watch results. (1988) (48)
Quantitative Results of Baseline Angiography and Percutaneous Coronary Intervention in the COURAGE Trial (2009) (47)
An epidemic of pulmonary hypertension after toxic rapeseed oil ingestion in Spain. (1983) (47)
Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. (2015) (47)
Efficacy and Safety of a Metabolic Modulator Drug in Chronic Stable Angina: Review of Evidence from Clinical Trials (2004) (46)
Diagnostic accuracy of dipyridamole technetium 99m-labeled sestamibi myocardial tomography for detection of coronary artery disease (1997) (46)
Asymptomatic Cardiac Ischemia Pilot (ACIP) study: effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemia. The ACIP investigators. (1995) (46)
ACC/AHA task force report. Special report: guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Sur (1996) (46)
Moderate alcohol feeding attenuates postinjury vascular cell proliferation in rabbit angioplasty model. (1997) (46)
Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease. (2020) (45)
Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial. (2003) (45)
Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. (2011) (45)
Effects of carbon monoxide exposure in patients with documented cardiac arrhythmias. (1993) (45)
Evaluation of left ventricular function during upright exercise: correlation of exercise Doppler with postexercise two-dimensional echocardiographic results. (1987) (44)
Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial. (2009) (44)
Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. (2008) (43)
Importance of myocardial infarct artery patency on the prevalence of ventricular arrhythmia and late potentials after thrombolysis in acute myocardial infarction. (1991) (43)
The effects of successful PTCA on left ventricular function: assessment by exercise echocardiography. (1989) (43)
Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI). (1999) (43)
Clinical and research issues regarding chronic advanced coronary artery disease: part I: Contemporary and emerging therapies. (2008) (42)
Standardized Definitions for Cardiovascular and Stroke Endpoint Events in Clinical Trials (2014) (42)
Asymptomatic Cardiac Ischemia Pilot (ACIP) study: impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes. The ACIP Investigators. (1995) (41)
The Psychophysiological Investigations of Myocardial Ischemia (PIMI) Study: Objective, Methods, and Variability of Measures (1998) (41)
Acute effects of carbon monoxide exposure on individuals with coronary artery disease. (1989) (41)
Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations main results of the guard during ischemia against necrosis (GUARDIAN) trial (2001) (40)
Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials. (2007) (39)
Methodology of serial ECG classification using an adaptation of the NOVACODE for Q wave myocardial infarction in the Bypass Angioplasty Revascularization Investigation (BARI). (1996) (39)
Five-year evaluation of the Carpentier-Edwards porcine bioprosthesis. (1984) (38)
Clinical and hemodynamic results with the Carpentier-Edwards porcine bioprosthesis. (1982) (38)
Differential Influence of Diabetes Mellitus on Increased Jeopardized Myocardium After Initial Angioplasty or Bypass Surgery: Bypass Angioplasty Revascularization Investigation (2002) (37)
Prolonged myocardial ischemia after intravenous dipyridamole thallium imaging. (1987) (37)
Association between new electrocardiographic abnormalities after coronary revascularization and five-year cardiac mortality in BARI randomized and registry patients. (2000) (37)
Prognostic significance of exercise thallium-201 testing in patients aged ≥70 years with known or suspected coronary artery (1992) (37)
Long-term survival of African Americans in the Coronary Artery Surgery Study (CASS). (1997) (36)
Late tears in leaflets of porcine bioprostheses in adults. (1984) (36)
Exercise testing in the Coronary Artery Surgery Study randomized population. (1985) (36)
Correlation of poststenotic hyperemic coronary flow velocity and pressure with abnormal stress myocardial perfusion imaging in coronary artery disease. (1996) (35)
Prognostic value of early exercise stress testing after successful coronary angioplasty: importance of the degree of revascularization. (1989) (34)
Histopathology after Nd-YAG laser percutaneous transluminal angioplasty of peripheral arteries. (1986) (34)
All-artery multigraft coronary artery bypass grafting with only internal thoracic arteries possible and safe: a randomized trial. (2000) (34)
Predictors of Mortality and Mortality From Cardiac Causes in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial and Registry (2000) (33)
Tolerance of unusually low mixed venous oxygen saturation. Adaptations in the chronic low cardiac output syndrome. (1986) (33)
Use of troponin assay 99th percentile as the decision level for myocardial infarction diagnosis (2017) (32)
Patent foramen ovale closure versus medical therapy in cases with cryptogenic stroke, meta-analysis of randomized controlled trials (2018) (32)
Myocardial cell damage by fatty acid ethyl esters. (1996) (32)
The prognosis in stable and unstable angina. (1991) (31)
Dipyridamole technetium 99m sestamibi myocardial tomography as an independent predictor of cardiac event-free survival after acute ischemic events (1994) (31)
Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial. (2013) (31)
Rationale and Design of the Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (WARRIOR) Trial. (2021) (31)
Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients With Cardiovascular Disease: The Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides Impact on Global Health Outcome (AIM–HIGH) Trial (2013) (30)
Expert Consensus Document. Third Universal Definition of Myocardial Infarction (2013) (30)
QT interval measurement by a computer assisted program: a potentially useful clinical parameter. (1982) (30)
Purification and characterization of human heart fatty acid ethyl ester synthase/carboxylesterase. (1996) (30)
Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience. (1997) (30)
Prospective Surveillance for Cardiac Adverse Events in Healthy Adults Receiving Modified Vaccinia Ankara Vaccines: A Systematic Review (2013) (29)
Risk stratification after successful coronary revascularization: the lack of a role for routine exercise testing. (2001) (28)
Prognostic value of dipyridamole thallium-201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation. (1998) (28)
Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial. (2016) (28)
A Review of the GUARDIAN Trial Results: Clinical Implications and the Significance of Elevated Perioperative CK‐MB on 6‐Month Survival (2003) (28)
Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes. (2019) (28)
Angina and Its Management (2017) (27)
High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. (2011) (27)
Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial. (2003) (27)
Risks and benefits of aortocoronary bypass surgery in patients aged 65 years or more. (1980) (27)
Deceleration‐dependent shortening of the qt interval: A new electrocardiographic phenomenon? (1999) (25)
Task Force I: Determination of prognosis in patients with ischemic heart disease. (1989) (25)
Anomalous left coronary artery from pulmonary artery. An eight year angiographic follow-up after saphenous vein bypass graft. (1975) (25)
Prognostic value of exercise thallium scintigraphy in patients with good exercise tolerance and a normal or abnormal exercise electrocardiogram and suspected or confirmed coronary artery disease. (1992) (25)
General Cardiology AbstractEffects of ranolazine with atenolol, amlodipine or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized, controlled trial (2004) (25)
Heparin versus aspirin after recombinant tissue plasminogen activator therapy in myocardial infarction: A randomized trial (1990) (25)
What is the true periprocedure myocardial infarction rate? Does anyone know for sure? The need for clarification. (1995) (24)
Prognostic Value of Adipokines in Predicting Cardiovascular Outcome: Explaining the Obesity Paradox. (2016) (24)
The role of coronary bypass surgery for 'left main equivalent' coronary disease: the Coronary Artery Surgery Study registry. (1986) (24)
ST Segment Elevation with Exercise: A Marker for Poor Ventricular Function and Poor Prognosis (1988) (23)
Aberrant course of the left anterior descending coronary artery assoicated with anomalous left circumflex origin from the pulmonary artery. (1975) (23)
Moving toward a new definition of acute myocardial infarction for the 21st century: status of the ESC/ACC consensus conference. European Society of Cardiology and American College of Cardiology. (2000) (23)
Effect of transient abrupt vessel closure during otherwise successful angioplasty for unstable angina on clinical outcome at six months. Hirulog Angioplasty Study Investigators. (1999) (23)
Restenosis after multilesion percutaneous transluminal coronary angioplasty. (1987) (22)
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Relationship between exercise-induced and ambulatory ischemia in patients with stable coronary disease. (1996) (22)
Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease (2019) (22)
Prognostic significance of silent myocardial ischemia detected by early treadmill exercise after coronary angioplasty. (1989) (21)
Factors predicting working status after aortocoronary bypass surgery. (1982) (21)
Effectiveness of percutaneous coronary intervention in patients with silent myocardial ischemia (post hoc analysis of the COURAGE trial). (2012) (21)
American College of Sports Medicine and American Heart Association joint position statement: automated external defibrillators in health/fitness facilities. (2011) (20)
The value of preoperative exercise testing in predicting long-term survival in patients undergoing aortocoronary bypass surgery. (1984) (20)
ORBITA revisited: what it really means and what it does not? (2018) (19)
Exercise treadmill testing using a modified exercise protocol in women with suspected myocardial ischemia: findings from the National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). (2005) (18)
Electrocardiography screening for cardiotoxicity after modified Vaccinia Ankara vaccination. (2009) (17)
Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial (2000) (17)
Clinical and Angiographic Risk Stratification and Differential Impact on Treatment Outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes ( BARI 2 D ) Trial (2012) (17)
Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c. (2013) (17)
Measuring antianginal drug efficacy using exercise testing for chronic angina: improved exercise performance with ranolazine, a pFOX inhibitor. (2002) (17)
Erratum: Correlation of pharmacological 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses (Circulation (1994) 89 (2150-2160)) (1994) (16)
The prognostic value of exercise testing. (1993) (16)
Task force 1: Training in clinical cardiology (1995) (16)
Application of computerized exercise ECG digitization. Interpretation in large clinical trials. (1992) (16)
Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization. (2020) (16)
Comparative antianginal effects of nisoldipine and nifedipine in patients with chronic stable angina. (1987) (15)
Stable angina pectoris: antianginal therapies and future directions (2012) (15)
Antianginal efficacy of omapatrilat in patients with chronic angina pectoris. (2005) (15)
Influence of left ventricular function and other parameters on early and late mortality following coronary bypass surgery. (1977) (15)
Diagnostic impact of thallium scintigraphy and cardiac fluoroscopy when the exercise ECG is strongly positive. (1984) (15)
Prognostic significance of exercise thallium-201 testing in patients aged greater than or equal to 70 years with known or suspected coronary artery disease. (1992) (14)
Perioperative cardiac evaluation for noncardiac surgery noninvasive cardiac testing. (1998) (14)
The role of exercise-induced silent myocardial ischemia in patients with abnormal left ventricular function. A report from the Coronary Artery Surgery Study (CASS) registry. (1989) (13)
Preoperative strategies to assess cardiac risk before noncardiac surgery (1995) (13)
Task force 2: training in electrocardiography, ambulatory electrocardiography, and exercise testing. (2008) (13)
Intravenous dipyridamole: body weight considerations and dosage requirements. (1989) (12)
False-Negative and False-Positive ECG Diagnoses of Q Wave Myocardial Infarction in the Presence of Right Bundle-Branch Block (2001) (12)
Should airline pilots be eligible to resume active flight status after coronary bypass surgery?: a CASS registry study. (1986) (12)
Should early acceleration of heart rate during exercise be used to risk stratify patients with suspected or established coronary artery disease? (2007) (12)
No reflow and the quest to achieve optimal perfusion during the acute phase of myocardial infarction. (2004) (12)
Open-heart surgery in elderly patients. (1983) (12)
Heterogeneity among cardiac ischemic and anginal responses to exercise, mental stress, and daily life. (1998) (11)
Thiazolidinediones and Risk of Atrial Fibrillation Among Patients with Diabetes and Coronary Disease. (2018) (11)
An off-line digital system for reproducible interpretation of the exercise ECG. (1990) (10)
Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease (2007) (10)
Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials. (2018) (10)
Noninvasive assessment of diastolic and systolic properties of ibopamine in patients with congestive heart failure. (1989) (10)
Third universal definition of myocardial (2012) (10)
Late development of left ventricular outflow tract obstruction after repair of double-outlet right ventricle. (1976) (10)
Atorvastatin for acute coronary syndromes. (2001) (9)
Sex Differences in Cardiac Troponin and the Risk of Death or Major Cardiovascular Events. (2016) (9)
Developed in Collaboration With the European Heart Rhythm Association and the Sudden Cardiac Death) Management of Patients With Ventricular Arrhythmias and the Prevention of Practice Guidelines (Writing Committee to Develop Guidelines for (2007) (9)
Ventriculography and coronary arteriography in the acutely III patient. Complications, extent of coronary arterial disease, and abnormalities of left ventricular function. (1976) (9)
Do Major Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial Differ by Healthcare System? (2010) (9)
Prognostic implications of quantitative evaluation of baseline Q-wave width in ST-segment elevation myocardial infarction. (2014) (9)
Outcomes of Participants With Diabetes in the ISCHEMIA Trials (2021) (8)
Standards for the function of an academic 12-lead electrocardiographic core laboratory. (2001) (8)
Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty: One-year TIMI phase II pilot results (1990) (8)
Significance of silent myocardial ischemia during exercise testing in women: report from the Coronary Artery Surgery Study. (1995) (8)
Right bundle branch block as a cause of false-negative ECG classification of inferior myocardial infarction. (1999) (8)
Ranolazine increases exercise performance and decreases hemoglobin A1C in angina patients with diabetes (2003) (8)
Images in clinical medicine. Electrocardiographic changes in intracranial hemorrhage mimicking myocardial infarction. (2003) (8)
Percutaneous balloon valvuloplasty and coronary angioplasty for the treatment of calcific aortic stenosis and obstructive coronary artery disease in an elderly patient. (1988) (8)
The Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Trial: Effects of Intensive Atorvastatin Treatment on Early Recurrent Events After an Acute Coronary Syndrome (2000) (8)
Should ECG be required in young athletes? (2008) (7)
Abstract 13798: Effect of Ranolazine on Atrial Fibrillation Among Patients with Non-ST Elevation Acute Coronary Syndromes (NSTEACS) - Observations from the MERLIN-TIMI 36 Trial (2011) (7)
Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial. (2021) (7)
The survival of nonoperated patients with ischemic heart disease: The cass experience (1982) (7)
Safe use of thrombolysis in the elderly. (1989) (7)
1099-87 Symptoms persist in patients with chronic angina despite frequent anti-anginal use and prior revascularization (2004) (7)
Human fatty acid ethyl ester synttiase-III gene: Genomic organization, nucleotide sequencing and chromosomal localization (1997) (7)
Role of exercise testing in relationship to coronary artery bypass surgery and percutaneous transluminal coronary angioplasty. (1986) (7)
Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial. (2022) (6)
Evaluation for Noncardiac Surgery) (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Cardiology/American Heart Association Task Force on Practice Guidelines Noncardiac Surgery—Executive Summary A Report of the American College of ACC/AHA Guideline Update for Perioperative Card (2008) (6)
Pharmacological approaches to the symptomatic treatment of chronic stable angina: a historical perspective and future directions. (2005) (6)
Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study). (1999) (6)
Carbon monoxide exposure of subjects with documented cardiac arrhythmias. (1992) (6)
Causes of Cardiovascular and Non-Cardiovascular Death in the ISCHEMIA Trial. (2022) (6)
Survival patterns in clinical and angiographic subsets of medically treated patients with combined proximal left anterior descending and proximal left circumflex coronary artery disease (CASS). (1989) (6)
Choice of initial medical therapy vs. prompt coronary revascularization in patients with type 2 diabetes and stable ischemic coronary disease with special emphasis on the BARI 2D trial results (2010) (6)
Exercise ECG test results in the TIMI II trial (1990) (5)
Council on Clinical Cardiology, American Heart Association Advisory From the Committee on Exercise, Rehabilitation, and Prevention, Assessment of Functional Capacity in Clinical and Research Applications : An (2008) (5)
Application of computerized exercise electrocardiogram digitizationinterpretation in large clinical trials (1990) (5)
Is ST segment elevation non-Q-wave myocardial infarction after thrombolytic therapy a new clinical entity that requires an invasive management strategy? (2001) (5)
Optimising diagnostic accuracy with the exercise ECG: opportunities for women and men with stable ischaemic heart disease (2016) (5)
Is the 99th Percentile the Optimal Reference Limit to Diagnose Myocardial Infarction With High-Sensitivity Cardiac Troponin Assays in Patients With Chronic Kidney Disease? (2015) (5)
Asymptomatic cardiac ischemia pilot (ACIP). (1995) (5)
Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial. (2015) (5)
Preoperative Clinical Assessment and Dipyridamole Thallium-201 Scintigraphy for Prediction and Prevention of Cardiac Events in Patients Having Major Noncardiovascular Surgery and Known or Suspected Coronary Artery Disease (1995) (5)
Clarifying the Proper Definitions for Type 2 Myocardial Infarction. (2018) (5)
Factors Influencing Clinical Outcomes After Revascularization in the Asymptomatic Cardiac Ischemia Pilot (ACIP) (1999) (5)
Newer concepts in the medical management of patients with congestive heart failure (1993) (5)
Technical consideration in multiple valve and coronary artery surgery. (1974) (4)
A gender-specific hazard-based clinical and noninvasive coronary risk scoring system for patients with suspected coronary artery disease. (1995) (4)
Heparinization of patients undergoing coronary arteriography. (1973) (4)
Hemodynamic evaluation of the Angell-Shiley porcine xenograft. (1982) (4)
Effect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial). (2015) (4)
Posterior myocardial infarction revisited. (1988) (4)
Guidelines for training in adult cardiovascular medicine. Core Cardiology Training Symposium (COCATS). Task Force 1: training in clinical cardiology. (1995) (4)
Factors Influencing Clinical Outcomes After Revascularization in the Asymptomatic Cardiac Ischemia Pilot (ACIP) (1985) (4)
THE CALCITONIN GENE-RELATED PEPTIDE RECEPTOR ANTAGONIST TELCAGEPANT DOES NOT REDUCE EXERCISE TOLERANCE IN PATIENTS WITH EXERCISE INDUCED MYOCARDIAL ISCHEMIA (2010) (4)
Analysis of ST-segment shift in lead AVR improves short-term prognostic risk stratification in acute coronary syndrome (2003) (4)
When should ranolazine be considered for the treatment of chronic angina? (2006) (4)
Abstract 10897: Effect of High-Dose Atorvastatin on Risk of Atrial Fibrillation in Patients with Prior Stroke or Transient Ischemic Attack: Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial (2010) (3)
New Electrocardiographic Criteria for Identifying the Culprit Artery in Inferior Wall Acute Myocardial Infarction—Usefulness of T-Wave Amplitude Ratio in Leads II/III and T-Wave Polarity in the Right V 5 Lead (2004) (3)
Risk of preangioplasty occlusion and myocardial infarction in one-vessel-disease patients scheduled for percutaneous transluminal coronary angioplasty. (1986) (3)
Myocardial infarct size and sex-related angiographic differences in myocardial infarction in nonobstructive coronary artery disease (2021) (3)
Ischemia With Nonobstructive Coronary Arteries: Insights From the ISCHEMIA Trial. (2022) (3)
Clinical Events Classification (CEC) in Clinical Trials: Report on the Current Landscape and Future Directions - Proceedings from the CEC Summit 2018. (2021) (3)
Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease. (2020) (3)
More on the saga of routine emergency coronary angioplasty for acute myocardial infarction. (1989) (3)
An alternate limb lead system for electrocardiograms in emergency patients. (1997) (3)
SUBSTANTIAL VARIABILITY BETWEEN LABORATORIES IN TROPONIN DECISION LEVEL FOR DIAGNOSIS OF MYOCARDIAL INFARCTION AND ASSAY 99TH PERCENTILE: FINDINGS FROM THE INTERNATIONAL STUDY OF COMPARATIVE HEALTH EFFECTIVENESS WITH MEDICAL AND INVASIVE APPROACHES (ISCHEMIA) TRIAL (2014) (3)
Effects of posture on metabolic and hemodynamic predischarge exercise response after acute myocardial infarction. (1990) (3)
Abstract 3362: Effects of Ranolazine as Monotherapy and Combination Therapy on Rate Pressure Product at Rest and During Exercise: Results from the MARISA and CARISA trials (2006) (3)
Abstract 2449: Clinical Outcomes in Women with Stable Coronary Artery Disease Randomized to Optimal Medical Therapy With or Without PCI: Pre-Specified Subset Analysis of the COURAGE Trial (2007) (2)
BARI 2D: A Reanalysis Focusing on Cardiovascular Events. (2019) (2)
IMPACT OF PRETREATMENT ISCHEMIA ON THERAPEUTIC RISK REDUCTION AND LONG-TERM PROGNOSIS IN PATIENTS WITH STABLE ANGINA: RESULTS FROM COURAGE TRIAL (2010) (2)
CORONARY ANATOMY, ISCHEMIA AND ANGINA: ASSOCIATIONS AT BASELINE IN THE ISCHEMIA TRIAL (2020) (2)
Should Exercise Myocardial Perfusion Imaging Be the Standard Noninvasive Approach for the Initial Evaluation of Symptomatic Women With Suspected Coronary Artery Disease? (2011) (2)
From the American Heart Association Exercise Standards for Testing and Training : A Statement for Healthcare Professionals (2013) (2)
Mutagenesis and characterization of specific residues in fatty acid ethyl ester synthase: A gene for alcohol-induced cardiomyopathy (1998) (2)
Diagnostic and prognostic exercise electrocardiography: What can nuclear cardiology gain from insights from the exercise laboratory — Challenge and speculation (1995) (2)
The use of electrocardiography as a diagnostic and prognostic tool in coronary artery disease (1992) (2)
What has happened to risk stratification with noninvasive testing (1996) (2)
The prevalence and prognostic significance of silent myocardial ischemia after coronary bypass surgery (1990) (2)
Is the 99 th Percentile the Optimal Reference Limit to Diagnose Myocardial Infarction with High Sensitivity Cardiac Troponin Assays in Patients with Chronic Kidney Disease? (2015) (2)
Duration of improved exercise performance following oral diltiazem in chronic stable angina (1982) (2)
189 Ranolazine decreases haemoglobin A1C (HbA1c) in angina patients with diabetes: carbohydrate and lipid parameters in MARISA and CARISA (2003) (2)
Identifying high yield sources of patients with coronary artery disease for clinical trials: Lessons from the asymptomatic cardiac ischemia pilot (ACIP) experience (1998) (2)
Coronary Artery Disease Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease (2013) (2)
Abstract 2447: Impact of Optimal Medical Therapy With or Without PCI on Long-term Cardiovascular Endpoints in Patients with Stable Coronary Artery Disease: Tertiary Outcomes from the COURAGE Trial (2007) (1)
Oral Diltiazem and Supraventricular Tachyarrhythmias (1985) (1)
Abstract 12697: Comparison of 1-Year Myocardial Perfusions Pattern by Randomized Treatment in Patients with Diabetes and Coronary Artery Disease and Relation to Clinical Outcomes: Results from the BARI 2D Trial (2010) (1)
Prognostic Risk Stratification After Acute Coronary Syndromes (2011) (1)
Response by Chaitman et al to Letter Regarding Article, "Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons". (2021) (1)
SEX DIFFERENCES IN STRESS TEST AND CCTA FINDINGS AND SYMPTOMS IN THE RANDOMIZED ISCHEMIA TRIAL (2020) (1)
PREDICTION OF LEFT MAIN DISEASE USING CLINICAL AND STRESS TEST PARAMETERS (2020) (1)
Coronary Heart Disease / Myocardial Infarction Diminished Vascular Response to Inhibition of Endothelium-Derived Nitric Oxide and Enhanced Vasoconstriction to Exogenously Administered Endothelin-1 in Clinically Healthy Smokers (2005) (1)
A Randomized Clinical Trial of Liberal Versus Restrictive Transfusion Strategy Evaluating Long Term Survival and Cause of Death: Results from the FOCUS Trial (2014) (1)
Risk Stratification: Exercise Testing, Imaging, and Cardiac Catheterization (1999) (1)
Left ventricular ejection fraction: an important but incomplete determinant of long-term outcome after coronary bypass surgery. (1996) (1)
Abstract 13030: Causes of Cardiovascular and Non-cardiovascular Mortality in the Ischemia Trial (2020) (1)
Reply: In regard to the TERISA trial. (2014) (1)
Training in clinical cardiology (1995) (1)
Increasing the Pre-Test Likelihood Estimate for Non-ST Elevation Myocardial Infarction in Acute Coronary Syndrome : Results from the GUARDIAN Trial (2003) (1)
Do all Q waves after coronary bypass surgery impact six-month prognosis? (2002) (1)
Clinical and detailed angiographic findings in patients with ambulatory electrocardiographic ischemia without critical coronary narrowing: Results from the asymptomatic cardiac ischemia pilot (ACIP) study (1998) (1)
Total occlusion of the left main coronary artery: The cass experience (1981) (1)
Abstract 2453: Effect of Ranolazine on Hemoglobin A1c in the MERLIN-TIMI 36 Randomized Controlled Trial (2007) (1)
Policies at Health/Fitness Facilities Recommendations for Cardiovascular Screening, Staffing, and Emergency (2009) (1)
Exaggerated exercise-induced sytolic blood pressure response: arterial baroreceptor sensitivity or carotid stiffness? (2018) (1)
Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial. (2023) (1)
Acute success of intravenous diltiazem in paroxysmal supraventricular tachyarrhythmias (1982) (1)
1023-96 A randomized double-blind placebo-controlled phase 2 study on the efficacy and safety of fasudil in patients with stable angina (2004) (1)
Association Between Blood Pressure Variability and Long Term Survival in Patients With Stable Ischemic Heart Disease: A Post-Hoc Analysis of the Courage Trial (2016) (1)
Predicting Six-Month Mortality in Acute Coronary Syndromes : Results from the GUARDIAN Trial (2003) (1)
An Academic ECG Core Lab Perspective of the FDA Initiative for Digital ECG Capture and Data Management in Large-Scale Clinical Trials* (2005) (1)
Initiating PCSK9 Inhibition in Hospital for ACS: We Can, But Does That Mean We Should? (2019) (1)
Periprocedure myocardial infarction rates in the bypass angioplasty revascularization investigation (BARI) (1996) (1)
Guidelines for training in adult cardiovascular medicine: Introduction (1995) (0)
Does low level carbon monoxide exposure have a proarrhythmic effect in patients with coronary artery disease and ventricular arrhythmia (1991) (0)
[Importance of the exercise electrocardiogram and of thallium scintigraphy of the myocardium in the evaluation of patients referred for percutaneous transluminal coronary angioplasty]. (1982) (0)
BASELINE EXERCISE CAPACITY AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE: A POST HOC ANALYSIS OF THE COURAGE TRIAL (2014) (0)
HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL IS ASSOCIATED WITH RESIDUAL RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DESPITE OPTIMAL LEVELS OF LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL: A POST HOC ANALYSIS FROM THE COURAGE TRIAL (2011) (0)
990-47 Absence of Ischemia on Ambulatory ECG Monitoring During Treatment as a Predictor of Outcome: A Report from the ACIP Study (1995) (0)
A NEW RISK PREDICTION TOOL TO ASSESS LONG-TERM PROGNOSIS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE (SIHD): THE “COURAGE RISK SCORE” (2011) (0)
[Cardiovascular effects of exercise and physical training in coronary disease]. (1979) (0)
Significance of diastolic aortic murmurs after aortic valve replacement (1983) (0)
Abstract 12675: High Sensitivity Cardiac Troponin T and B-Type Natriuretic Peptide Predict Death and Major Cardiovascular Events but Not Benefit From Immediate Revascularization in Type 2 Diabetes and Stable Ischemic Heart Disease: A BARI 2D Substudy (2014) (0)
Relationship Among Mental Stress-Induced Ischemia During Daily Life and During Exercise: The Psychophysiologic Investigations of Myocardial Ischemia (PIMI) Study (1999) (0)
Molecular Epidemiology of SARS — From Amoy Gardens to Taiwan (2003) (0)
Abstract 17574: Effects of Ranolazine on Disease-Specific Health Status and Quality of Life Among Patients With Diabetes and Stable Angina: Results From the TERISA Randomized Trial (2013) (0)
Interphysician versus computer-assisted intrepretation of exercise electrocardiograms (1990) (0)
CLINICAL Prognostic Value of Dipyridamole Thafum-201 Imaging in Elderly Patients (2016) (0)
BASELINE EXERCISE CAPACITY AND IMPROVEMENT IN QUALITY OF LIFE IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE: A POST HOC ANALYSIS OF THE COURAGE TRIAL (2014) (0)
Abstract 18327: Angiographic Criteria Determine Effectiveness of CABG among Patients with Diabetes and Stable Ischemic Heart Disease: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial (2010) (0)
EFFECT OF PERCUTANEOUS REVASCULARIZATION ADDED TO OPTIMAL MEDICAL THERAPY ON CLINICAL OUTCOMES IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION, HEART FAILURE, OR REDUCED SYSTOLIC FUNCTION: A POST HOC ANALYSIS OF THE COURAGE TRIAL (2016) (0)
The Pulmonary Complications of AIDS (2017) (0)
Post-Test Risk of Obstructive Coronary Disease After a Symptom-Limited Exercise Test in Patients Without Previous Myocardial Infarction (2010) (0)
The year in review: electrocardiogram analysis and acute coronary syndromes (2020) (0)
Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial (2022) (0)
[Quantitative analysis of exercise test results in the diagnosis of coronary disease]. (1979) (0)
One-year TIMI II pilot results. (1990) (0)
Erratum: Mutagenesis and characterization of specific residues in fatty acid ethyl ester synthase: A gene for alcohol-induced cardiomyopathy (Molecular and cellular biochemistry (1998) 180 (111-115)) (2000) (0)
10: 30 a.m.: VENTRICULAR FUNCTION IN SUPINE AND UPRIGHT EXERCISE AFTER CORONARY BYPASS SURGERY (1981) (0)
Transluminal Coronary Angioplasty (2005) (0)
Abstract 15078: Effects of Glucose Control and Coronary Revascularization Strategies on Cardiac Troponin and Natriuretic Peptide Levels in Patients with Type 2 Diabetes and Stable Ischemic Heart Disease: a BARI-2D Substudy (2014) (0)
Abstract 188: Comparison of Physician- and Patient-Assessed Impressions of Treatment Efficacy: Insights from the TERISA Clinical Trial (2014) (0)
Application to Specific Populations Coronary Artery Disease (2000) (0)
Dipyridamole thallium imaging for prognosis in elderly patients (1991) (0)
Abstract 208: No Independent Association Between Extended-Release Niacin (ERN) Therapy and Ischemic Stroke in Patients with Established Cardiovascular Disease: A Detailed Analysis from the AIM HIGH Trial (2013) (0)
Prognosis of patients without myocardial necrosis after thrombolytic therapy: A TIMI II data bank study (1991) (0)
Clinical Selection Criteria and Role of Noninvasive Testing for PTCA (1986) (0)
Using estimated functional capacity to optimize stress testing for diagnosis and prognosis of cardiovascular disease in women: The NHLBI-sponsored WISE study (2003) (0)
Coronary Artery Disease Prevalence in Men with Stable Chest Pain and No History of Myocardial Infarction (2005) (0)
Health/Fitness Facilities Recommendations for Cardiovascular Screening, Staffing, and Emergency Policies at (2013) (0)
Abstract 2345: Does Myocardial Perfusion Imaging During Dobutamine Stress Echocardiography Provides Incremental Prognostic Information In Women With Suspected Coronary Artery Disease? (2006) (0)
Abstract 11930: Sex Differences in Cardiac Troponin and the Risk of Death or Major Cardiovascular events in Men and Women With Diabetes and Coronary Artery Disease (2015) (0)
[Comparison of the cumulative survival among patient groups with a left main coronary artery lesion after surgical and therapeutic treatment]. (1982) (0)
Professionals From the American Heart Association Exercise Standards for Testing and Training: A Statement for Healthcare (2008) (0)
Comparative 5 year incidence of ischemic events for PTCA and CABG in the Bypass Angioplasty Revascularization Investigation (BARI) (1996) (0)
Abstract 16865: Long-Term Clinical Outcomes of Patients with Type 4a Myocardial Infarction Following Elective PCI for Stable Ischemic Heart Disease (SIHD): Post Hoc Analysis of the COURAGE Trial (2012) (0)
Stress Testing After Acute Myocardial Infarction (1988) (0)
Effect of Age and Relation to Mortality on Serial Changes of Vasoactive Intestinal Peptide ir Acute Myocardial Infarction (1996) (0)
Abstract 12577: Markers of Residual Risk in Type 2 Diabetes and Stable Ischemic Heart Disease: Insights From the BARI 2D Trial (2016) (0)
PATHOPHYSIOLOGY AND NATURAL HISTORY CORONARY ARTERY DISEASE (2005) (0)
PREVALENCE AND CLINICAL SIGNIFICANCE OF RECURRENT AND UNREMITTING ANGINA WITH PERCUTANEOUS INTERVENTION VERSUS OPTIMAL MEDICAL THERAPY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE: A POST HOC ANALYSIS OF THE CLINICAL OUTCOMES UTILIZING REVASCULARIZATION AND AGGRESSIVE DRUG EVALUATION TRIAL (2013) (0)
Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. (2022) (0)
Women Versus Men Regarding Outcome of CABG or PTCA Response (1999) (0)
Abstract 10145: Multifactorial Risk of Cardiac Mortality and Myocardial Infarction in Type 2 Diabetes Mellitus. A BARI 2D Substudy (2010) (0)
Abstract 12072: Predictors of Cardiovascular and Non-Cardiovascular Death: From the Clinic to the Lab (2014) (0)
Diabetes does not add to the increased six-month mortality associated with increase in CK-MB after percutaneous coronary intervention (2003) (0)
Abstract 10383: Comparative Assessment of Medical Therapy, PCI, or CABG on Clinical Outcomes in Diabetic Patients With Stable CAD According to Coronary Angiography and Left Ventricular Function: Patient-level Meta-analysis of the BARI-2D, COURAGE, and FREEDOM Trials (2015) (0)
Abstract 17725: Frequency and Prognostic Importance of Troponin and CK-MB Elevations Following Coronary Artery Bypass Grafting: An Analysis from PRIMO I and PRIMO II (2012) (0)
Bioprosthesis Versus Mechanical Devices (1988) (0)
The cardiac troponin T concentration was an independent predictor of death from cardiovascular causes, myocardial infarction, or stroke (2015) (0)
What we can learn from exercise thallium testing of the elderly (1992) (0)
Ari Cedars Giovanni Filardo (2017) (0)
[Valve replacement in aged patients. Risk and remote results]. (1983) (0)
[Diagnostic value of electrocardiography and thallium 201 scintigraphy combined with exercise following coronary disease]. (1979) (0)
Does one-year outcome after acute myocardial infarction differ with race? Results from the TIMI II trial (1991) (0)
1028-66 Clinical and Demographic Findings in Patients with Ischemia and “Normal” Coronary Arteries: An ACIP Ancillary Study (1995) (0)
Assessment of ACC exercise test guidelines for screening asymptomatic subjects: Experience with police officers (1991) (0)
Comparative side effect profile and safety of intravenous adenosine versus dipyridamole radionuclide imaging (1991) (0)
Abstract 11383: Glucose-Lowering Medications and Angina Burden in Patients With Stable Coronary Disease. Results From the TERISA Trial (2014) (0)
Purification and characterization of human heart fatty acid ethyl ester synthase/carboxylesterase. (1997) (0)
MANAGEMENT AND OUTCOMES OF PATIENTS WITH DIABETES MELLITUS (DM) AND STABLE ISCHEMIC HEART DISEASE (SIHD): POOLED DATA FROM THE ISCHEMIA AND ISCHEMIA-CKD TRIALS (2021) (0)
[Must the medical treatment of vasospastic angina be continued indefinitely?]. (1983) (0)
Prognostic value of exercise thallium scintigraphy in elderly patients (1991) (0)
for Young Patients With Genetic Cardiovascular Diseases Recommendations for Physical Activity and Recreational Sports Participation (2007) (0)
Comparative hemodynamic evaluation of the carpentieredwards and angell-shiley porcine xenografts (1980) (0)
Rationale and Design for the Myocardial Ischemia and Transfusion (MINT) Randomized Clinical Trial. (2022) (0)
Impact of High-Density Lipoprotein Cholesterol on Revascularization Procedures in Patients With Stable Ischemic Heart Disease: From the COURAGE trial* (2014) (0)
exercise and the heart Prolonged Myocardial Ischemia after Intravenous Dipyridamole Thallium lmaging * (2006) (0)
RELATIONSHIP OF HEALTH STATUS TO ISCHEMIA AND CORONARY ANATOMY IN THE ISCHEMIA TRIAL (2022) (0)
Grafting: Results of the EXPEDITION Study Ischemic Cardiac Events in Patients Undergoing Coronary Artery Bypass Sodium-Hydrogen Exchange Inhibition by Cariporide to Reduce the Risk of (2013) (0)
Abstract 19993: Burden of Coronary Atherosclerosis and Cardiovascular Events in Men and Women with Stable Ischemic Heart Disease (2014) (0)
New Findings from BARI 2D (2009) (0)
Abstract 20094: Achieved Blood Pressure Targets and Cardiovascular Outcomes in Stable Ischemic Heart Disease: a Post Hoc Analysis from the COURAGE trial (2014) (0)
[Present situation of interpreting computerized electrocardiography]. (1982) (0)
Comments and Discussion on the Cocoa-platelet Presentation (2006) (0)
Manual of exercise testing by Victor F. Froelicher and Gilberto D. Marcondes year book Medical Publishers, Inc., Chicago (1989) 332 pages, illustrated, $34.95 ISBN: 0–8151–3364–2 (1991) (0)
[Use of the ECG under physical load for assessing the status of ischemic heart disease patients]. (1982) (0)
Comparative diagnostic value of exercise polarcardiography and 14-lead electrocardiography in the detection of coronary artery disease. (1985) (0)
Utility of post-procedure CK-MB ratio and ECG changes in clinical trials to predict early mortality following coronary bypass surgery (2000) (0)
Abstract 12742: Myocardial Infarct Size and Sex-Related Angiographic Differences in MINOCA (Myocardial Infarction in Non-Obstructive Coronary Artery Disease) (2018) (0)
MYOCARDIAL INFARCTION RATES BY DEFINITION, TYPE, AND TREATMENT IN THE ISCHEMIA-CKD TRIAL (2021) (0)
Ranolazine as Add-on Therapy for Patients With Severe Chronic Angina—Reply (2004) (0)
for routine exercise testing Risk stratification after successful coronary revascularization: the lack of a role (2011) (0)
Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty: one-year TIMI phase II pilot results. TIMI Investigators. (1990) (0)
Exercise and the Heart (1995) (0)
Predicting early coronary revascularization after an acute coronary syndrome (2003) (0)
[Coronary percutaneous transluminal angioplasty: initial results in our first 110 patients]. (1982) (0)
Does the Angiogram Still Qualify as the Gold Standard for Evaluation of Noninvasive Tests (2002) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bernard r. Chaitman?

Bernard r. Chaitman is affiliated with the following schools:

Bernard r. Chaitman's Academic­Influence.com Rankings

Why Is Bernard r. Chaitman Influential?

Bernard r. Chaitman's Published Works

Published Works

What Schools Are Affiliated With Bernard r. Chaitman?

Bernard r. Chaitman's AcademicInfluence.com Rankings